Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H10O5 |
Molecular Weight | 270.2369 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC2=C(C(O)=C1)C(=O)C3=C(C=C(O)C=C3O)C2=O
InChI
InChIKey=RHMXXJGYXNZAPX-UHFFFAOYSA-N
InChI=1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3
Molecular Formula | C15H10O5 |
Molecular Weight | 270.2369 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Emodin is a naturally occurring anthraquinone present in the roots of numerous plants and lichens and an active ingredient of various Chinese herbs. Emodin possesses various biological properties and serves as an anti-bacterial and anti-inflammatory agent. Emodin was studied as a potential anti-cancer agent: e.g., it was shown, that compound inhibits the invasion and migration of colon cancer cells in vitro and in vivo by blocking EMT, which is related with the inhibition of Wnt/β-catenin signaling pathway. Besides, emodin effectively ameliorates asthmatic airway inflammation and alternatively activated macrophages (AAMs) polarization, and thus can be a potential agent for the treatment of asthma. It is known that the Inhibition of AAMs is an alternative therapeutic strategy for treating asthma. Some experiments have revealed that emodin can be a beneficial dietary supplement in prolonging lifespan.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Wnt/β-catenin signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/29301594 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Cloning and expression of a rat liver phenobarbital-inducible UDP-glucuronosyltransferase (2B12) with specificity for monoterpenoid alcohols. | 1995 Oct 1 |
|
Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. | 1996 Sep 3 |
|
Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor beta1 and fibronectin by human peritoneal mesothelial cells. | 2001 |
|
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues. | 2001 Dec 17 |
|
In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus. | 2001 Mar |
|
Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma. | 2001 Sep |
|
Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5. | 2001 Sep |
|
Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. | 2002 Dec 15 |
|
Screening of the inhibitory effect of vegetable constituents on the aryl hydrocarbon receptor-mediated activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. | 2003 Dec |
|
Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. | 2003 Dec |
|
Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. | 2003 Dec |
|
Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9. | 2003 Jul 25 |
|
Transcriptional suppression of the HIV promoter by natural compounds. | 2003 Mar |
|
Neuraminidase inhibitors from Reynoutria elliptica. | 2003 May |
|
Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. | 2004 Apr |
|
Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. | 2004 Aug |
|
Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. | 2004 Jan 1 |
|
Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake. | 2004 Jan 9 |
|
Evaluation of a real-time polymerase chain reaction method for the quantification of CYP1B1 gene expression in MCF-7 human breast carcinoma cells. | 2004 Mar-Apr |
|
Synthesis and biological evaluation of new derivatives of emodin. | 2004 Nov 15 |
|
Influence of functional group substitutions on the carcinogenicity of anthraquinone in rats and mice: analysis of long-term bioassays by the National Cancer Institute and the National Toxicology Program. | 2005 Mar-Apr |
|
The effect of emodin-assisted early enteral nutrition on severe acute pancreatitis and secondary hepatic injury. | 2007 |
|
Emodin induces apoptosis through caspase 3-dependent pathway in HK-2 cells. | 2007 Mar 7 |
|
Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. | 2008 Aug 20 |
|
Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. | 2008 Dec |
|
The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin. | 2008 Mar 14 |
|
Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity? | 2009 |
|
Emodin targets the beta-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: enzymatic inhibition assay with crystal structural and thermodynamic characterization. | 2009 May 12 |
|
Validation of a new yeast-based reporter assay consisting of human estrogen receptors alpha/beta and coactivator SRC-1: application for detection of estrogenic activity in environmental samples. | 2009 Oct |
|
Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells. | 2010 Apr |
|
Apoptosis induced by emodin is associated with alterations of intracellular acidification and reactive oxygen species in EC-109 cells. | 2010 Aug |
|
Screening medicinal plants for the detection of novel antimalarial products applying the inhibition of β-hematin formation. | 2011 Dec 15 |
|
Emodin and [6]-gingerol lessen hypoxia-induced embryotoxicities in cultured mouse whole embryos via upregulation of hypoxia-inducible factor 1α and intracellular superoxide dismutases. | 2011 May |
|
Inhibition of cytochrome p450 enzymes by quinones and anthraquinones. | 2012 Feb 20 |
|
Effects of an anthraquinone derivative from Rheum officinale Baill, emodin, on airway responses in a murine model of asthma. | 2012 Jul |
|
Emodin induces embryonic toxicity in mouse blastocysts through apoptosis. | 2012 Sep 4 |
|
Emodin inhibits human sperm functions by reducing sperm [Ca(2+)]i and tyrosine phosphorylation. | 2015 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29417945
murine asthma model: intraperitoneal injection of emodin (20 mg·kg-1·d-1, ip) 1 h prior to DRA (dust mite, ragweed and aspergillus) challenge on days 12-14 significantly decreased pulmonary eosinophil and lymphocyte infiltration, mucus secretion and serum IgE production, as well as IL-4 and IL-5 production in bronchoalveolar lavage fluid.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18407913
The potential for emodin to inhibit pancreatic cancer cell proliferation was examined using 4 human pancreatic adenocarcinoma cell lines: Mia Paca-2, BxPC-3, Panc-1, and L3.6pl. Forty-eight-hour treatment with 50 muM emodin inhibited proliferation in Mia Paca-2 cells by 42%, BxPc-3 by 38%, L3.6pl by 56%, and Panc-1 by 18% (all P < .01). In three-fourths of the cell lines, emodin treatment resulted in an increase (from 4.7% to 22%) in the cell population number in apoptosis when measured by flow cytometric analysis
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:23:01 UTC 2023
by
admin
on
Fri Dec 15 15:23:01 UTC 2023
|
Record UNII |
KA46RNI6HN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1967
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3220
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
KA46RNI6HN
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
1235059
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
m4888
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID5025231
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
100000126306
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
EMODIN
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
622947
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
42223
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
208-258-8
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
408120
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
D004642
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
77659
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
7093
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
C466
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
518-82-1
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
SUB33038
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY | |||
|
DB07715
Created by
admin on Fri Dec 15 15:23:01 UTC 2023 , Edited by admin on Fri Dec 15 15:23:01 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |